Cytovale website screenshot

Cytovale

Cytovale is a San Francisco-based medical diagnostics company that develops early-detection technology for sepsis. Its flagship product, IntelliSep, is the first and only FDA-cleared in vitro diagnostic test for sepsis: it uses microfluidics, high-speed video, and computer-vision algorithms to measure the biophysical rigidity of tens of thousands of white blood cells, detecting the immune activation that signals sepsis risk and returning a risk stratification in roughly eight minutes. The test runs on the Cytovale System medical device in emergency-department settings. Cytovale is venture-backed by Norwest Venture Partners, Sands Capital, and the Global Health Investment Corporation. The company operates as a clinical/diagnostics device maker and does not currently publish a public developer API, SDK, or API documentation surface.

Cytovale is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Diagnostics, Medical Devices, and Sepsis.

Cytovale’s developer surface includes support, engineering blog, and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub
16.2/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealthcareDiagnosticsMedical DevicesSepsisIn Vitro DiagnosticsClinical

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 16.2/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 5.3 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cytovale: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Cytovale Domain Security

TLSv1.3 · DMARC

SECURITY

Cytovale Trust Center

SOC 2, GDPR

SECURITY

Resources

Access & Security 3

Authentication, authorization, and security posture

Compliance
Compliance
 TrustCenter
TrustCenter
 DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: cytovale
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/cytovale.png
name: Cytovale
description: 'Cytovale is a San Francisco-based medical diagnostics company that develops early-detection technology for sepsis.
  Its flagship product, IntelliSep, is the first and only FDA-cleared in vitro diagnostic test for sepsis: it uses microfluidics,
  high-speed video, and computer-vision algorithms to measure the biophysical rigidity of tens of thousands of white blood
  cells, detecting the immune activation that signals sepsis risk and returning a risk stratification in roughly eight minutes.
  The test runs on the Cytovale System medical device in emergency-department settings. Cytovale is venture-backed by Norwest
  Venture Partners, Sands Capital, and the Global Health Investment Corporation. The company operates as a clinical/diagnostics
  device maker and does not currently publish a public developer API, SDK, or API documentation surface.'
url: https://raw.githubusercontent.com/api-evangelist/cytovale/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- norwest-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Healthcare
- Diagnostics
- Medical Devices
- Sepsis
- In Vitro Diagnostics
- Clinical
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://cytovale.com
- type: Support
  url: https://cytovale.com/support/contact-information/
- type: Blog
  url: https://cytovale.com/about/news-and-events/
- type: PrivacyPolicy
  url: https://cytovale.com/privacy-statement-us/
- type: Compliance
  url: https://cytovale.com/security-compliance/
- type: TrustCenter
  url: security/cytovale-trust-center.yml
- type: DomainSecurity
  url: security/cytovale-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence